A randomized trial of an early measles vaccine at 4 1/2 months of age in Guinea-Bissau: Sex-differential immunological effects

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Jensen, Kristoffer Jarlov ^a,b,c   Søndergaard, Mia ^c   Andersen, Andreas ^a   Sartono, Erliyani ^d   Martins, Cesario ^c   Garly, May Lill ^c   Eugen Olsen, Jesper ^e   Ullum, Henrik ^f   Yazdanbakhsh, Maria ^d   Aaby, Peter ^a,c   Benn, Christine Stabell ^a,c,g   Erikstrup, Christian ^h  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Mental Health Services CPH   (Denmark)

^f Rigshospitalet   (Denmark)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MEASLES VACCINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; RETINOL; SOLUBLE UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; CCL2 PROTEIN, HUMAN; CYTOKINE;

ARTICLE; CONTROLLED STUDY; FEMALE; GUINEA-BISSAU; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INFANT; MALE; MEASLES; MEASLES VACCINATION; MORTALITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; VITAMIN SUPPLEMENTATION; BLOOD; IMMUNOLOGY; METABOLISM; REGRESSION ANALYSIS;

CHEMOKINE CCL2; CYTOKINES; FEMALE; GUINEA-BISSAU; HUMANS; INFANT; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-8; MALE; MEASLES; MEASLES VACCINE; REGRESSION ANALYSIS; SEX FACTORS; VITAMIN A;

EID: 84901328667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097536     Document Type: Article

References (26)

1. Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, et al. (2011) Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 204: 245-252.
2. Aaby P, Martins CL, Garly ML, Bale C, Andersen A, et al. (2010) Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 341: c6495.
3. Aaby P, Jensen H, Rodrigues A, Garly ML, Benn CS, et al. (2004) Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. IntJEpidemiol 33: 367-373. (Pubitemid 38578838)
4. Aaby P, Benn C, Nielsen J, Lisse IM, Rodrigues A, et al. (2012) Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2.
5. Liu L, Johnson HL, Cousens S, Perin J, Scott S, et al. (2012) Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379: 2151-2161.
6. Ovsyannikova IG, Reid KC, Jacobson RM, Oberg AL, Klee GG, et al. (2003) Cytokine production patterns and antibody response to measles vaccine. Vaccine 21: 3946-3953. (Pubitemid 37338222)
7. Schnorr JJ, Cutts FT, Wheeler JG, Akramuzzaman SM, Alam MS, et al. (2001) Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine 19: 1503-1510. (Pubitemid 32332736)
8. Eriksson M, Sartono E, Martins CL, Bale C, Garly ML, et al. (2007) A comparison of ex vivo cytokine production in venous and capillary blood. Clin Exp Immunol 150: 469-476. (Pubitemid 350098738)
9. Jorgensen MJ, Fisker AB, Sartono E, Andersen A, Erikstrup C, et al. (2012) The effect of at-birth vitamin A supplementation on differential leucocyte counts and in vitro cytokine production: an immunological study nested within a randomised trial in Guinea-Bissau. Br J Nutr: 1-11.
10. Ostrowski SR, Ullum H, Goka BQ, Hoyer-Hansen G, Obeng-Adjei G, et al. (2005) Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome. J Infect Dis 191: 1331-1341.
11. Uh HW, Hartgers FC, Yazdanbakhsh M, Houwing-Duistermaat JJ (2008) Evaluation of regression methods when immunological measurements are constrained by detection limits. BMC Immunol 9: 59.
12. Andersen A (2012) Statistical Analysis of Population-Based Immunological Studies: Faculty of Health and Medical Sciences, University of Copenhagen.
13. Newson RB (2010) Frequentist q-values for multiple-test procedures. The Stata Journal 10 (4): 568-584.
14. Baggiolini M (2001) Chemokines in pathology and medicine. J Intern Med 250: 91-104.
15. Chae P, Im M, Gibson F, Jiang Y, Graves DT (2002) Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment. Infect Immun 70: 3164-3169. (Pubitemid 34564180)
16. Peters W, Dupuis M, Charo IF (2000) A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. J Immunol 165: 7072-7077. (Pubitemid 32001181)
17. Eckmann L, Kagnoff MF, Fierer J (1993) Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 61: 4569-4574. (Pubitemid 23320507)
18. Gabay C, Lamacchia C, Palmer G (2010) IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6: 232-241.
19. Njie-Jobe J, Nyamweya S, Miles DJ, van der Sande M, Zaman S, et al. (2012) Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years. Vaccine 30: 2543-2550.
20. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, et al. (2012) Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 109: 17537-17542.
21. Benn CS, Bale C, Sommerfelt H, Friis H, Aaby P (2003) Hypothesis: Vitamin A supplementation and childhood mortality: amplification of the non-specific effects of vaccines? Int J Epidemiol 32: 822-828. (Pubitemid 37304648)
22. Benn CS, Fisker AB, Jorgensen MJ, Aaby P (2008) Conflicting evidence for neonatal vitamin A supplementation. Vaccine 26: 4111-4112.
23. Benn CS, Rodrigues A, Yazdanbakhsh M, Fisker AB, Ravn H, et al. (2009) The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination. Vaccine 27: 2891-2898.
24. Aaby P, Samb B, Simondon F, Seck AM, Knudsen K, et al. (1995) Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 311: 481-485.
25. Rager-Zisman B, Bazarsky E, Skibin A, Tam G, Chamney S, et al. (2004) Differential immune responses to primary measles-mumps-rubella vaccination in Israeli children. Clin Diagn Lab Immunol 11: 913-918. (Pubitemid 39280598)
26. Snopov SA, Kharit SM, Norval M, Ivanova VV (2005) Circulating leukocyte and cytokine responses to measles and poliovirus vaccination in children after ultraviolet radiation exposures. Arch Virol 150: 1729-1743. (Pubitemid 41176632)